Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    9321530 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Crohn's Disease
Condition: Crohn Disease
Interventions: Drug: Infliximab 5 mg/kg;   Drug: Infliximab 10 mg/kg;   Drug: Infliximab 20 mg/kg;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.